Clinical trial
IdB 1016 Treatment for Hepatitis C Disease
NCT00055445 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00055445 |
|---|---|
| Title | IdB 1016 Treatment for Hepatitis C Disease |
| Official title | IdB 1016 in Hepatitis C |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C, Chronic |
| Intervention type | Drug |
| Interventions | IdB 1016 |
| Enrollment | 45 |
| Start date | Nov 1, 2003 |
| Completion | Apr 1, 2006 |
| First posted | Mar 4, 2003 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: